Bharat Biotech had applied for emergency use authorisation for its vaccine candidate, Covaxin, in Nepal on January 13. Covaxin demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials India.
The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or between 45 to 60 years with comorbidities can receive vaccination.
India's indigenously developed vaccine against coronavirus COVAXIN has demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR, informed vaccine maker Bharat Biotech.
A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country's immunisation campaign, cyber intelligence firm Cyfirma told Reuters.
Chinese and Russian-linked hacking campaigns in recent weeks targeted Indian vaccine makers Serum Institute of India (SII) and Bharat Biotech, cyber intelligence and threat discovery platform Cyfirma said on Monday.
Union Minister Ravi Shankar Prasad on March 01 said that Prime Minister Narendra Modi has replied to all the people questioning that when will he get vaccinated. He further requested Opposition to unite in efforts against Corona rather than using it as a political tool.
Prime Minister Narendra Modi took his first dose of the COVAXIN (Bharat Biotech) at Delhi's AIIMS on March 01 as the second phase of vaccination drive began in India today.
Makers of Covaxin, Bharat Biotech has said that they can modify the vaccine against coronavirus South African variant within 15 days. Bharat Biotech's developed India's own vaccine Covaxin against Covid-19 and was rolled out on January 16.
Global healthcare company GSK, non-profit agency working to end health inequity PATH, and vaccine maker Bharat Biotech on Wednesday announced the signing of a product transfer agreement for malaria vaccine RTS,S/AS01E1.
India will start supplying hundreds of thousands of doses of ‘Covishield’ vaccine on a grant basis to key neighbours beginning with 2,50,000 vaccine doses for Bhutan and Maldives. Other countries like Bangladesh and Nepal are likely to receive their supplies on Thursday.
Ninety-two countries have approached India for Covid-19 vaccines, bolstering New Delhi's credentials as the vaccine hub of the world.
Out of the 45 lakh doses, the city-based vaccine maker will be supplying over eight lakh to some of the friendly countries such as Mauritius, Philippines and Myanmar, free of cost as good will gesture sources added.
Covaxin is one of the two drugs approved for emergency use in India. It is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National Institute of Virology.
The Union Health Ministry on Saturday asked the Ministry of External Affairs (MEA) to consider contacting Bharat Biotech for the procurement of 8.1 lakh doses of Covaxin to be given to different countries as a goodwill gesture.
Amid the rollout of the world's largest Covid-19 vaccination programme by Prime Minister Narendra Modi, here are a few things that you need to know about the two vaccines -- 'Covaxin' and 'Covishield' -- selected by the Drugs Controller General of India (DCGI).
Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company will pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.
At a time when vaccine distribution to states across India is in full swing ahead of the January 16 launch, the Congress party has raised questions on the safety, compatibility of India's homegrown Covid vaccine named COVAXIN, asking the government how it can be rolled out when it is yet to clear phase-3 trials.
The first batch of Covaxin, Covid-19 vaccine by Bharat Biotech, landed at the Delhi airport from Hyderabad on Wednesday morning.
The first phase of the COVID-19 vaccination drive is scheduled to start from January 16. Health Secretary Rajesh Bhushan said that the Central government is having a close collaboration with states and union territories for vaccine roll-out.
Bharat Biotech on Tuesday announced it has signed an agreement with Precisa Medicamentos for the supplies of its Covid vaccine 'Covaxin' to Brazil.
Top News
Latest News
